Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA

European Journal of Neurology

Volumn 23, Issue 1, 2016, Pages 175-181

  Guo, S ^a   Esserlind, A L ^a   Andersson, Z ^a   Frederiksen, A L ^b   Olesen, J ^a   Vissing, J ^a   Ashina, M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Headache; mDNA 3243A>G; Migraine; Mitochondrial dysfunction; Mutation

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MUTATION; PREVALENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DENMARK; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MUTATION; PREVALENCE; YOUNG ADULT;

EID: 84954527876     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12832     Document Type: Article

References (47)

1. Montagna P, Sacquegna T, Martinelli P, et al. Mitochondrial abnormalities in migraine. Preliminary findings. Headache 1988; 28: 477-480.
2. Shimomura T, Kowa H, Nakano T, et al. Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 1994; 14: 215-218; discussion 181.
3. Skinhoj E. Hemodynamic studies within the brain during migraine. Arch Neurol 1973; 29: 95-98.
4. Okada H, Araga S, Takeshima T, Nakashima K. Plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. Headache 1998; 38: 39-42.
5. Uncini A, Lodi R, Di Muzio A, et al. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci 1995; 129: 214-222.
6. Sangiorgi S, Mochi M, Riva R, et al. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia 1994; 14: 21-23.
7. Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 1989; 39: 538-541.
8. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 2006; 26: 361-372.
9. Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia 2009; 29: 719-728.
10. Majamaa K, Moilanen JS, Uimonen S, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998; 63: 447-454.
11. Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991; 1097: 238-240.
12. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992; 42: 545-550.
13. Koo B, Becker LE, Chuang S, et al. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 1993; 34: 25-32.
14. Montagna P, Gallassi R, Medori R, et al. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology 1988; 38: 751-754.
15. The International Classification of Headache Disorders. 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.
16. Cevoli S, Pallotti F, La Morgia C, et al. High frequency of migraine-only patients negative for the 3243 A>G tRNALeu mtDNA mutation in two MELAS families. Cephalalgia 2010; 30: 919-927.
17. Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 1995; 24: 612-618.
18. Esserlind A-L, Kirchmann M, Hauge AW, Le H, Olesen J. A genotype-phenotype analysis of the 8q22.1 variant in migraine with aura. Eur J Neurol 2012; 19: 603-609.
19. Rasmussen BK, Jensen R, Olesen J. Questionnaire versus clinical interview in the diagnosis of headache. Headache 1991; 31: 290-295.
20. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. 3rd edn. New York: Wiley, 2003.
21. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44: 1147-1157.
22. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267: 64-69.
23. Fornuskova D, Brantova O, Tesarova M, et al. The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. Biochim Biophys Acta 2008; 1782: 317-325.
24. Dubeau F, De Stefano N, Zifkin BG, Arnold DL, Shoubridge EA. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann Neurol 2000; 47: 179-185.
25. Betts J, Lightowlers RN, Turnbull DM. Neuropathological aspects of mitochondrial DNA disease. Neurochem Res 2004; 29: 505-511.
26. Frederiksen AL, Andersen PH, Kyvik KO, Jeppesen TD, Vissing J, Schwartz M. Tissue specific distribution of the 3243A→G mtDNA mutation. J Med Genet 2006; 43: 671-677.
27. Majamaa K, Finnilä S, Turkka J, Hassinen IE. Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet 1998; 352: 455-456.
28. Haan J, Terwindt GM, Maassen JA, Hart LM, Frants RR, Ferrari MD. Search for mitochondrial DNA mutations in migraine subgroups. Cephalalgia 1999; 19: 20-22.
29. Ojaimi J, Katsabanis S, Bower S, Quigley A, Byrne E. Mitochondrial DNA in stroke and migraine with aura. Cerebrovasc Dis 1998; 8: 102-106.
30. Rozen TD, Shanske S, Otaegui D, et al. Study of mitochondrial DNA mutations in patients with migraine with prolonged aura. Headache 2004; 44: 674-677.
31. Klopstock T, May A, Seibel P, Papagiannuli E, Diener HC, Reichmann H. Mitochondrial DNA in migraine with aura. Neurology 1996; 46: 1735-1738.
32. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ 1995; 311: 541-544.
33. Barbiroli B, Montagna P, Cortelli P, et al. Complicated migraine studied by phosphorus magnetic resonance spectroscopy. Cephalalgia 1990; 10: 263-272.
34. Barbiroli B, Montagna P, Cortelli P, et al. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992; 42: 1209-1214.
35. Sacquegna T, Lodi R, De Carolis P, et al. Brain energy metabolism studied by 31P-MR spectroscopy in a case of migraine with prolonged aura. Acta Neurol Scand 1992; 86: 376-380.
36. Reyngoudt H, Paemeleire K, Descamps B, De Deene Y, Achten E. 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients. Cephalalgia 2011; 31: 1243-1253.
37. Di Gennaro G, Buzzi MG, Ciccarelli O, et al. Assessing the relative incidence of mitochondrial DNA A3243G in migraine without aura with maternal inheritance. Headache 2000; 40: 568-571.
38. Buzzi MG, Di Gennaro G, D'Onofrio M, et al. mtDNA A3243G MELAS mutation is not associated with multigenerational female migraine. Neurology 2000; 54: 1005-1007.
39. Rajasimha HK, Chinnery PF, Samuels DC. Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A→G mutation in blood. Am J Hum Genet 2008; 82: 333-343.
40. Aurora SK, Welch KMA, Al-Sayed F. The threshold for phosphenes is lower in migraine. Cephalalgia 2003; 23: 258-263.
41. Kann O, Kovács R, Njunting M, et al. Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans. Brain 2005; 128: 2396-2407.
42. Kovács R, Kardos J, Heinemann U, Kann O. Mitochondrial calcium ion and membrane potential transients follow the pattern of epileptiform discharges in hippocampal slice cultures. J Neurosci 2005; 25: 4260-4269.
43. Di Lorenzo C, Coppola G, Sirianni G, et al. Migraine improvement during short lasting ketogenesis: a proof-of-concept study. Eur J Neurol 2015; 22: 170-177.
44. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008; 7: 500-506.
45. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998; 50: 466-470.
46. Sándor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005; 64: 713-715.
47. Di Lorenzo C, Pierelli F, Coppola G, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology 2009; 72: 1588-1594.